Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Assessment of insulin sensitivity in type 2 diabetics treated with metformin, fenofibrate and their combination
2005-003347-31Phase 3Terminated
- Sponsor
- Fournier
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of metformin and fenofibrate in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Fournier. Primary endpoint: Percent change of low-dose insulin-suppressed endogenous glucose production (EGP). Started Mar 2006; status: terminated.
02
Drugs
metforminfenofibrate
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2005-003347-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003347-31.